Stachydrine prevents LPS-induced bone loss by inhibiting osteoclastogenesis via NF-κB and Akt signalling.
Meng J, Zhou C, Zhang W, Wang W, He B, Hu B, Jiang G, Wang Y, Hong J, Li S, He J, Yan S, Yan W.
Meng J, et al. Among authors: yan w, yan s.
J Cell Mol Med. 2019 Oct;23(10):6730-6743. doi: 10.1111/jcmm.14551. Epub 2019 Jul 21.
J Cell Mol Med. 2019.
PMID: 31328430
Free PMC article.